Ekso Bionics Holdings, Inc. (LON:0IFR)
London
· Delayed Price · Currency is GBP · Price in USD 0.3727
-0.0175 (-4.48%)
At close: Apr 9, 2025
Ekso Bionics Holdings Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Revenue | 17.93 | 18.28 | 12.91 | 11.25 | 8.88 | Upgrade
|
| Revenue Growth (YoY) | -1.94% | 41.57% | 14.81% | 26.62% | -36.18% | Upgrade
|
| Cost of Revenue | 8.41 | 9.2 | 6.7 | 4.5 | 3.81 | Upgrade
|
| Gross Profit | 9.51 | 9.08 | 6.21 | 6.75 | 5.07 | Upgrade
|
| Selling, General & Admin | 16.69 | 19.71 | 18.75 | 18.56 | 15.99 | Upgrade
|
| Research & Development | 3.29 | 4.48 | 3.02 | 2.02 | 1.94 | Upgrade
|
| Operating Expenses | 19.97 | 24.19 | 21.77 | 20.58 | 17.93 | Upgrade
|
| Operating Income | -10.46 | -15.11 | -15.56 | -13.83 | -12.86 | Upgrade
|
| Interest Expense | -0.27 | -0.3 | -0.16 | -0.11 | -0.14 | Upgrade
|
| Currency Exchange Gain (Loss) | -0.97 | 0.35 | -0.69 | -0.88 | 0.99 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.47 | -0.13 | 1.32 | 3.96 | -3.39 | Upgrade
|
| EBT Excluding Unusual Items | -11.22 | -15.2 | -15.08 | -10.86 | -15.39 | Upgrade
|
| Merger & Restructuring Charges | - | - | - | - | -0.24 | Upgrade
|
| Impairment of Goodwill | - | - | - | - | -0.19 | Upgrade
|
| Other Unusual Items | -0.11 | - | - | 1.1 | - | Upgrade
|
| Pretax Income | -11.33 | -15.2 | -15.08 | -9.76 | -15.83 | Upgrade
|
| Net Income | -11.33 | -15.2 | -15.08 | -9.76 | -15.83 | Upgrade
|
| Net Income to Common | -11.33 | -15.2 | -15.08 | -9.76 | -15.83 | Upgrade
|
| Shares Outstanding (Basic) | 20 | 14 | 13 | 12 | 7 | Upgrade
|
| Shares Outstanding (Diluted) | 20 | 14 | 13 | 12 | 7 | Upgrade
|
| Shares Change (YoY) | 45.39% | 6.98% | 5.65% | 71.26% | 49.44% | Upgrade
|
| EPS (Basic) | -0.56 | -1.10 | -1.16 | -0.80 | -2.21 | Upgrade
|
| EPS (Diluted) | -0.56 | -1.10 | -1.16 | -0.88 | -2.21 | Upgrade
|
| Free Cash Flow | -9.88 | -12.21 | -14.88 | -11.22 | -8.76 | Upgrade
|
| Free Cash Flow Per Share | -0.49 | -0.88 | -1.15 | -0.91 | -1.22 | Upgrade
|
| Gross Margin | 53.06% | 49.67% | 48.13% | 60.01% | 57.08% | Upgrade
|
| Operating Margin | -58.35% | -82.67% | -120.48% | -122.96% | -144.77% | Upgrade
|
| Profit Margin | -63.21% | -83.14% | -116.79% | -86.82% | -178.17% | Upgrade
|
| Free Cash Flow Margin | -55.13% | -66.80% | -115.26% | -99.72% | -98.57% | Upgrade
|
| EBITDA | -8.85 | -13.41 | -14.67 | -12.81 | -12.24 | Upgrade
|
| EBITDA Margin | -49.38% | -73.39% | -113.61% | -113.86% | -137.78% | Upgrade
|
| D&A For EBITDA | 1.61 | 1.7 | 0.89 | 1.02 | 0.62 | Upgrade
|
| EBIT | -10.46 | -15.11 | -15.56 | -13.83 | -12.86 | Upgrade
|
| EBIT Margin | -58.35% | -82.67% | -120.48% | -122.96% | -144.77% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.